Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 2154

Journal of Biotechnology & Biomaterials received 2154 citations as per Google Scholar report

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Access to Global Online Research in Agriculture (AGORA)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Recommended Journals
Share This Page

Ruchkina Irina Nikolaevna

Central Research Institute of Gastroenterology, Department of Treatment Inflammatory Bowel Diseases, Russia

Biography

Dr. Ruchkina is a Gastroenterologist. Graduated with honors from the Moscow State Medical and Dental University named after A. I. Evdokimov in 1984. From 1986 to 1988.  she studied in clinical residency at the Russian National Research Medical University named after N. I. Pirogov at the Department of Gastroenterology and Therapy. In 1996, he defended his PhD thesis on the topic: "Irritable bowel syndrome", and in 2005-his doctoral dissertation "The role of acute intestinal infections and microbiocenosis disorders in the etiology and pathogenesis of irritable bowel syndrome". 
Publications

Safety of Mesenchymal Stem Cells Therapy in Patients with Inflammatory Bowel Diseases 5 Year Follow-Up

Aim: To compare safety profile of therapy in patients with ulcerative colitis (UC) and Crohn disease (СD), receiving anti-inflammatory therapy, using bone marrow-derived mesenchymal stromal cells (MSC) and standard therapy with 5-aminosalicylic acid (5-ASA), glucocorticosteroids (GCS) and immunosuppressive agents (IS). Materials and... Read More»

Knyazev Oleg Vladimirovich, Parfenov Asfold Ivanovich, Konoplaynnikov Anatoliy Georgievich, Kagramanova Anna Valeryevna, Churikova Alevtina Alekseevna, Ruchkina Irina Nikolaevna, Lishinskaya Albina Aleksandrovna, Boldireva Oksana Nikolaevna and Fadeeva Nina Aleksandrovna

Research Article: J Biotechnol Biomater 2015, 5:192

DOI: 10.4172/2155-952X.1000192

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Top